Acadian Asset Management
FRLN

Acadian Asset Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Acadian Asset Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,797
Closed -$4K – 1903
2023
Q2 		$4K Sell
1,797
-1
-0.1% -$4 ﹤0.01% 1689
2023
Q1 		$12K Hold
1,798
– – ﹤0.01% 1682
2022
Q4 		$12K Hold
1,798
– – ﹤0.01% 1733
2022
Q3 		$18K Hold
1,798
– – ﹤0.01% 1610
2022
Q2 		$23K Hold
1,798
– – ﹤0.01% 1603
2022
Q1 		$30K Buy
+1,798
New +$33.4K ﹤0.01% 1522

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Acadian Asset Management's FRLN Position: Q3 2023 in Review

Acadian Asset Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2023, closing a stake of 1,797 shares — an estimated $4K sold.

Acadian Asset Management first reported a position in FRLN in Q1 2022 and held it in 6 quarters. The position peaked at $30K in Q1 2022. 12 funds tracked by Wall St. Rank hold FRLN as of Q3 2023.

  • Acadian Asset Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 1,797 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2023, an estimated $4K.
  • Acadian Asset Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q1 2022 and held it in 6 quarters.
  • Acadian Asset Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $30K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.